EP0617618A1 - Aryl-triflates and related compounds - Google Patents
Aryl-triflates and related compoundsInfo
- Publication number
- EP0617618A1 EP0617618A1 EP93901666A EP93901666A EP0617618A1 EP 0617618 A1 EP0617618 A1 EP 0617618A1 EP 93901666 A EP93901666 A EP 93901666A EP 93901666 A EP93901666 A EP 93901666A EP 0617618 A1 EP0617618 A1 EP 0617618A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- substituted
- compound
- compounds
- mmol
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/30—Inkjet printing inks
- C09D11/32—Inkjet printing inks characterised by colouring agents
- C09D11/324—Inkjet printing inks characterised by colouring agents containing carbon black
- C09D11/326—Inkjet printing inks characterised by colouring agents containing carbon black characterised by the pigment dispersant
Abstract
L'invention se rapporte à des aryltriflates et à des composés associés représentés par la formule générale (1), où Ar représente un système aromatique ou hétéroaromatique d'un composé qui possède une activité biologique thérapeutique lorsque, dans la même position, il porte un groupe hydroxy, alkyloxy, halo, ester ou cyano; où R1 représente CF3, (C1-C8)alkyle, -CH2-(C3-C8)cycloalkylalkyle, phényle substitué, benzyle substitué, phényléthyle substitué, phénylpropyle substitué, 2-thiophényléthyle substitué ou 2-thiophénylpropyle substitué. Ces composés possèdent de bonnes propriétés à la fois pharmacodynamiques et pharmacocynétiques et ils sont par conséquent utiles comme médicaments.The invention relates to aryltriflates and associated compounds represented by the general formula (1), where Ar represents an aromatic or heteroaromatic system of a compound which has therapeutic biological activity when, in the same position, it carries a hydroxy, alkyloxy, halo, ester or cyano group; where R1 represents CF3, (C1-C8) alkyl, -CH2- (C3-C8) cycloalkylalkyl, substituted phenyl, substituted benzyl, substituted phenylethyl, substituted phenylpropyl, substituted 2-thiophenylethyl or substituted 2-thiophenylpropyl. These compounds have good pharmacodynamic and pharmacokinetic properties and are therefore useful as medicaments.
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9103745A SE9103745D0 (en) | 1991-12-18 | 1991-12-18 | ARYL-TRIFLATES AND RELATED COMPOUNDS |
SE9103745 | 1991-12-18 | ||
PCT/DK1992/000389 WO1993011761A1 (en) | 1991-12-18 | 1992-12-18 | Aryl-triflates and related compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0617618A1 true EP0617618A1 (en) | 1994-10-05 |
Family
ID=20384643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93901666A Withdrawn EP0617618A1 (en) | 1991-12-18 | 1992-12-18 | Aryl-triflates and related compounds |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0617618A1 (en) |
JP (1) | JPH08504744A (en) |
AU (1) | AU3255993A (en) |
CA (1) | CA2126242A1 (en) |
FI (1) | FI942931A (en) |
NO (1) | NO942296D0 (en) |
SE (1) | SE9103745D0 (en) |
WO (1) | WO1993011761A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002227135B2 (en) * | 2000-10-31 | 2008-01-03 | Rensselaer Polytechnic Institute | 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
ES2292758T3 (en) | 2001-03-29 | 2008-03-16 | Eli Lilly And Company | N- (2-ARILETIL) BENCILAMINS AS ANTAGONISTS OF THE 5-HT6 RECEIVER. |
AU2003219913A1 (en) * | 2002-02-27 | 2003-09-09 | Teva Pharmaceutical Industries, Ltd. | Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors |
TW200744576A (en) | 2006-02-24 | 2007-12-16 | Teva Pharma | Propargylated aminoindans, processes for preparation, and uses thereof |
US20090312306A1 (en) * | 2006-07-20 | 2009-12-17 | Guangri Sun | Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |
EP3569234A1 (en) | 2009-12-04 | 2019-11-20 | Alkermes Pharma Ireland Limited | Morphinan derivatives for the treatment of drug overdose |
JP5964809B2 (en) | 2010-03-22 | 2016-08-03 | レンセラール ポリテクニック インスティチュート | Morphine derivatives containing carboxamide groups as opioid receptor ligands |
HUE041981T2 (en) | 2010-08-23 | 2019-06-28 | Alkermes Pharma Ireland Ltd | Methods for treating antipsychotic-induced weight gain |
WO2012138888A1 (en) | 2011-04-05 | 2012-10-11 | Alkermes, Inc. | Process for the synthesis of quaternary amine compounds |
HUE034326T2 (en) | 2011-06-29 | 2018-02-28 | Alkermes Inc | Peripherally acting opioid compounds |
LT3153171T (en) | 2011-12-15 | 2018-12-10 | Alkermes Pharma Ireland Limited | Samidorphan (alks 33) in combination with buprenorphine for the treatment of depressive disorders |
US9211293B2 (en) | 2011-12-15 | 2015-12-15 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
JO3459B1 (en) | 2012-09-09 | 2020-07-05 | H Lundbeck As | Pharmaceutical compositions for treating alzheimer's disease |
EP3004114B1 (en) | 2013-05-24 | 2019-12-25 | Alkermes Pharma Ireland Limited | Morphan and morphinan analogues, and methods of use |
WO2014190271A2 (en) | 2013-05-24 | 2014-11-27 | Alkermes Pharma Ireland Limted | Methods for treating depressive symptoms |
WO2022101444A1 (en) | 2020-11-12 | 2022-05-19 | Alkermes Pharma Ireland Limited | Immediate release multilayer tablet |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3725451A (en) * | 1970-04-13 | 1973-04-03 | Riker Laboratories Inc | Substituted benzoylhaloalkanesulfonanilides |
DE3132167A1 (en) * | 1981-08-14 | 1983-03-03 | Hoechst Ag, 6000 Frankfurt | "5 (6) -PHENYLSULFONYLOXY-BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING IT AND THEIR USE AGAINST LIVER RULES" |
DE3232959A1 (en) * | 1982-09-04 | 1984-03-08 | Hoechst Ag, 6230 Frankfurt | SUBSTITUTED Benzenesulfonic Acid Ester, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS |
DE3243158A1 (en) * | 1982-11-23 | 1984-05-24 | Basf Ag, 6700 Ludwigshafen | NEW SULPHONIC ACID ESTERS OF HYDROXYCUMARINES, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM |
DE3247615A1 (en) * | 1982-12-23 | 1984-07-05 | Hoechst Ag, 6230 Frankfurt | SUBSTITUTED PHENYLSULFONYLOXYBENZIMIDAZOLE CARBAMINATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT |
US4470991A (en) * | 1983-04-22 | 1984-09-11 | Merck & Co., Inc. | Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure |
FR2557570B1 (en) * | 1984-01-04 | 1986-04-18 | Adir | NEW QUINOLEIN DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
DE3509333A1 (en) * | 1985-03-15 | 1986-09-18 | Hoechst Ag, 6230 Frankfurt | SUBSTITUTED BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE AS AN INGESTIC ACID INHIBITOR |
DE3521761A1 (en) * | 1985-06-19 | 1987-01-02 | Bayer Ag | NEW 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS |
DE3630903A1 (en) * | 1986-09-11 | 1988-03-24 | Thomae Gmbh Dr K | NEW TETRAHYDRONAPHTHALINE AND INDANDERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THEM |
GB8804016D0 (en) * | 1988-02-22 | 1988-03-23 | Boots Co Plc | Therapeutic agents |
DE3807813A1 (en) * | 1988-03-10 | 1989-09-21 | Thomae Gmbh Dr K | NEW BENZOCYCLOHEPEN DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
SE8901889D0 (en) * | 1989-05-26 | 1989-05-26 | Astra Ab | NOVEL 8-SUBSTITUTED-2-AMINOTETRALINES |
SE8904361D0 (en) * | 1989-12-22 | 1989-12-22 | Astra Ab | NEW CHROMAN AND THIOCHROMAN DERIVATIVES |
KR920004385A (en) * | 1990-08-09 | 1992-03-27 | 와꾸나가 기스께 | New tricyclic compounds or salts thereof, preparation method thereof and antimicrobial agent containing same |
-
1991
- 1991-12-18 SE SE9103745A patent/SE9103745D0/en unknown
-
1992
- 1992-12-18 WO PCT/DK1992/000389 patent/WO1993011761A1/en not_active Application Discontinuation
- 1992-12-18 EP EP93901666A patent/EP0617618A1/en not_active Withdrawn
- 1992-12-18 JP JP5510538A patent/JPH08504744A/en active Pending
- 1992-12-18 CA CA002126242A patent/CA2126242A1/en not_active Abandoned
- 1992-12-18 AU AU32559/93A patent/AU3255993A/en not_active Abandoned
-
1994
- 1994-06-17 NO NO942296A patent/NO942296D0/en unknown
- 1994-06-17 FI FI942931A patent/FI942931A/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO9311761A1 * |
Also Published As
Publication number | Publication date |
---|---|
SE9103745D0 (en) | 1991-12-18 |
JPH08504744A (en) | 1996-05-21 |
CA2126242A1 (en) | 1993-06-24 |
FI942931A0 (en) | 1994-06-17 |
AU3255993A (en) | 1993-07-19 |
WO1993011761A1 (en) | 1993-06-24 |
NO942296L (en) | 1994-06-17 |
NO942296D0 (en) | 1994-06-17 |
FI942931A (en) | 1994-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0617618A1 (en) | Aryl-triflates and related compounds | |
FR2567885A1 (en) | 3-AMINOPROPOXYARYLIC DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
EP0373998B1 (en) | Propenone oxime ethers, method for their preparation and pharmaceutical compositions containing them | |
LU81453A1 (en) | NEW INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS | |
RU2513856C2 (en) | Method of obtaining methyl ether of 4-oxooctahydroindole-1-carboxylic acid and its derivatives | |
JP2750187B2 (en) | Therapeutically effective tetralin derivatives | |
KR100193981B1 (en) | Novel 8-Substituted-2-aminotetralines | |
WO2005118547A1 (en) | Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics | |
KR900003883B1 (en) | 3,4-dihydro-2h- (1) - (benzopyran and benzothiopyran) -3-amines and their preparation | |
EP1096926B1 (en) | Methods and compounds for treating depression | |
EP1057826A1 (en) | Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them | |
FR2548666A1 (en) | New nortropane and granatane derivatives, process for their preparation and their application in therapeutics | |
EP1828125B1 (en) | Arylpiperazine derivatives and their use as ligangs selective of the dopamine d3 receptor | |
JPH02744A (en) | Compound active to cardiovascular system | |
EP0620221A1 (en) | 5-Acylamino-1,2,4-thiadiazoles as cholecystokinine antagonists or agonists | |
JPH0747585B2 (en) | Isoxazole derivative | |
EP0452204B1 (en) | 3-Aminochromane derivatives, procedure for their preparation and pharmaceutical compositions containing them | |
EP0998471B1 (en) | Substituted heterocyclic compounds, method for preparing and compositions containing same | |
EP1466604B1 (en) | Isoquinoline derivatives, process for their preparation and use thereof in the treatment of melatoninergic system problems | |
EP0053964A1 (en) | 1(4-Quinolyl)ethanol or propanol derivatives, pharmaceutical compositions containing them and processes for their preparation | |
EP0382618B1 (en) | Aminoalkoxyphenyl derivatives, process for their preparation and compositions containing them | |
EP0135489B1 (en) | Benzofuran derivatives, their preparation and their therapeutical use | |
FR2462438A1 (en) | NOVEL DERIVATIVES OF 6-ALKYL-7-PHENYL-1,6-NAPHTHYRIDINE-5 (6H) -ONE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS | |
CA2031839A1 (en) | Piperidine derivatives, preparation thereof and pharmaceutical compositions containing the same | |
JPH06507906A (en) | Carboxamide-(3,2N)-carbocyclic-2-aminotetralin derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19940630 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: H. LUNDBECK A/S |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: WIKSTROEM, HAKAN VILHELM |
|
17Q | First examination report despatched |
Effective date: 19960701 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19961112 |